Pimavanserin for Psychosis in Parkinson’s Disease-Related Disorders: A Retrospective Chart Review.

Pimavanserin for Psychosis in Parkinson’s Disease-Related Disorders: A Retrospective Chart Review.
Related ArticlesPimavanserin for Psychosis in Parkinson's Disease-Related Disorders: A Retrospective Chart Review. Drugs Aging. 2019 Mar 29;: Authors: Sellers J, Darby RR, Farooque A, Claassen DO Abstract BACKGROUND: Psychosis is common in Parkinson's disease-related disorders and is associated with significant morbidity. Pimavanserin is a newly approved treatment for Parkinson's disease psychosis, but real-world experience with pimavanserin has been limited by ... read more
Source: PubMedPublished on 2019-03-30